Correction to: Scientific Reports https://doi.org/10.1038/s41598-024-83484-3, published online 09 January 2025
The original version of this Article contained errors in Figure 4, where the graph in panel D was a duplicate of the graph in panel F.
The original Figure 4 and accompanying legend appear below.
SDG counters CTX-induced toxicity in granulosa cells via PI3K/Akt pathway modulation. (A) The cell viability of KGN treated with different concentrations of CTX. (B) The cell viability of KGN treated with different concentrations of SDG and 500 μm CTX. (C–F) The expression levels of PI3K/Akt pathway proteins in KGN cells after treatment with 500 μm CTX or co-treatment with 500 μm CTX and 400 μm SDG. (G) The microscopic morphology of KGN cells after treatment with 500 μm CTX or co-treatment with 500 μm CTX and 400 μm SDG. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 versus control. #p < 0.05, ##p < 0.01, ###p < 0.001 versus CTX group.
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Zhang, Y., Liu, X., Zheng, Z. et al. Correction: Network pharmacology uncovers that secoisolariciresinol diglucoside ameliorate premature ovarian insufficiency via PI3K/Akt pathway. Sci Rep 15, 33724 (2025). https://doi.org/10.1038/s41598-025-22129-5
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-025-22129-5
